{"project/01 immunogenic chemotherapy/202209271124_oxcy-project-5.md":{"scroll":0,"cursor":{"from":{"ch":8,"line":6},"to":{"ch":8,"line":6}}},"reference/cell_dendritic.md":{"scroll":0,"cursor":{"from":{"ch":113,"line":12},"to":{"ch":113,"line":12}}},"panels/panel_murine-hybrid-survey-01.md":{"scroll":10.227,"cursor":{"from":{"ch":36,"line":24},"to":{"ch":36,"line":24}}},"project/01 immunogenic chemotherapy/202209271048_oxcy-project-4.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":0},"to":{"ch":0,"line":0}}},"reference/cell_cytotoxic-t.md":{"scroll":2.5232,"cursor":{"from":{"ch":11,"line":12},"to":{"ch":11,"line":12}}},"daily/2022-10-10.md":{"scroll":0,"cursor":{"from":{"ch":23,"line":4},"to":{"ch":23,"line":4}}},"logs/2022-10-03 Tseng Lab Meeting.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":0},"to":{"ch":0,"line":0}}},"logs/2022-10-03 Barnado Lab Meeting.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":0},"to":{"ch":0,"line":0}}},"pathway_jak-stat.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":3},"to":{"ch":0,"line":3}}}}